U.S. Military Investigates Supplement Ingredient DMAA, Bans Sales
This article was originally published in The Tan Sheet
Executive Summary
DoD suspends DMAA sales at military stores after regulators in Canada and New Zealand restricted access and as some U.S. firms change how they market and label the ingredient. These moves and the potential for an FDA review could lead to enforcement against DMAA similar to the 2004 ban against ephedra’s use in supplements.
You may also be interested in...
Ephedra Back On Regulatory Radar As Supplement Adulterant
FDA acknowledges that enforcement activity on ephedra has been a lower priority than other adulterants since the agency banned ephedrine alkaloids in supplements in 2004. “The presumption was that it was banned and people were abiding by the law,” says FDA supplement official Daniel Fabricant.
Supplement Industry Must Step Up As Adulteration Threat Grows – FDA
The supplement industry has not done enough to aid FDA in pursuing firms adulterating products with drugs or getting the message out about adulteration, the agency says. Increased vigilance is needed especially as bad actors become more sophisticated and expand their adulteration activities.
Hydroxycut Recall Eyed As Trigger For Closer Look At Supplement AERs
The dietary supplement industry looks to FDA's Hydroxycut investigation for a sign on whether the agency will analyze adverse event reports more closely following a high-profile product recall